For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP32

2128

Dr.Soumya Basanth
Membership No Author Name Email Mobile
2128 Dr.Soumya Basanth soumyabasanth@yahoo.com 9845277198
Cornea, Ocular Surface and External Eye Diseases

To compare the outcomes of treatment with IRPL versus IRPL + Lifitegrast

Purpose: To compare the efficacy of Intense Regulated Pulsed Light (IRPL) alone versus IRPL combined with Lifitegrast 5% in patients with meibomian gland dysfunction (MGD)-associated dry eye disease.

Methods: In this comparative study, patients with MGD-related dry eye received either IRPL alone or IRPL plus topical Lifitegrast 5%. Outcomes included Ocular Surface Disease Index (OSDI), tear film break-up time (TBUT), corneal fluorescein staining, Schirmer’s test, and meibomian gland function, assessed at baseline and follow-up.

Results: Both groups showed significant clinical improvement. However, the IRPL plus Lifitegrast group demonstrated greater improvement in OSDI, TBUT, corneal staining, and meibomian gland function than the IRPL-alone group.

Conclusion: The addition of Lifitegrast to IRPL provides superior improvement in signs and symptoms of MGD-associated dry eye compared with IRPL alone, supporting combined therapy as an effective treatment strategy.

No Co-Author Selected